Loading
Latest filing published 07 Aug 2026 for OKYO Pharma Ltd, €6,469. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
All filings by John P. Brancaccio on record concern OKYO Pharma Ltd. We count 3 filings; the first trade dates from 15 September 2023 and the latest from 21 July 2026.
Purchases make up the whole of the open-market record (2 purchases, €30k). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. Since January 2026: 1 purchase and no sales on the market.
The latest filing, published on 7 August 2026, reports an open-market purchase of €6,469 in OKYO Pharma Ltd. Filings reach the SEC (Form 4) feed a median of 13 days after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations